119 related articles for article (PubMed ID: 10328475)
21. Anaphylaxis to Haemaccel and cross reactivity to Gelofusin.
Russell WJ; Fenwick DG
Anaesth Intensive Care; 2002 Aug; 30(4):481-3. PubMed ID: 12180589
[TBL] [Abstract][Full Text] [Related]
22. [Use of gelofusin in the clinics of the St. Petersburg's I.P. Pavlov State Medical University].
Baryshev BA; Doĭnikov DN; Khabarova IG; Kovalev MG
Vestn Khir Im I I Grek; 1998; 157(2):51-4. PubMed ID: 9691382
[TBL] [Abstract][Full Text] [Related]
23. [Preliminary study of colloid osmotic pressure for cardiopulmonary bypass].
Wang D; Xiang L; Luo J
Zhonghua Wai Ke Za Zhi; 1996 Dec; 34(12):751-3. PubMed ID: 9590779
[TBL] [Abstract][Full Text] [Related]
24. [Effectiveness and safety of using 6% hydroxyethyl starch 130/04 and 4% modified liquid gelatin in neurosurgical patients with massive intraoperative blood loss].
Israelian LA; Lubnin AIu
Anesteziol Reanimatol; 2009; (5):42-8. PubMed ID: 20491145
[TBL] [Abstract][Full Text] [Related]
25. Fluid management in cardiac surgery: is one hydroxyethyl starch solution safer than another?
Haynes GR
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):916-7. PubMed ID: 17138110
[No Abstract] [Full Text] [Related]
26. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects.
de Jonge E; Levi M; Berends F; van der Ende AE; ten Cate JW; Stoutenbeek CP
Thromb Haemost; 1998 Feb; 79(2):286-90. PubMed ID: 9493577
[TBL] [Abstract][Full Text] [Related]
27. [Effect of different colloid volume-replacing solutions on a changed hemostasis system].
Bulanov AIu; Gorodetskiĭ VM; Shulutko EM; Vasil'ev SA; Orel EB; Malofeev VN; Shcherbakova OV; Mamonov VE; Strel'nikova TB
Anesteziol Reanimatol; 2004; (2):25-30. PubMed ID: 15206272
[No Abstract] [Full Text] [Related]
28. [Clinical experience with the use of gelofusin (gelatin) in anesthesiology, resuscitation and intensive care].
Eremenko AA; Kuslieva EV
Anesteziol Reanimatol; 2001; (3):58-61. PubMed ID: 11510363
[TBL] [Abstract][Full Text] [Related]
29. Effects of gelatine and medium molecular weight starch as priming fluid in cardiopulmonary bypass--a randomised controlled trial.
Yap WW; Young D; Pathi V
Perfusion; 2007 Jan; 22(1):57-61. PubMed ID: 17633136
[TBL] [Abstract][Full Text] [Related]
30. [Incidence of anaphylactoid reactions following infusion with colloid volume substitutes].
Ring J; Seifert J; Struif E; Messmer K; Brendel W
Chir Forum Exp Klin Forsch; 1977 Apr; ():31-5. PubMed ID: 87295
[TBL] [Abstract][Full Text] [Related]
31. Difficulties with infusing new preparation of Gelofusine.
Hough M
Anaesthesia; 1994 Jan; 49(1):87-8. PubMed ID: 8311237
[No Abstract] [Full Text] [Related]
32. [Anaphylactic shock after infusion of a modified gelatin solution. Hemodynamic study].
Blanloeil Y; Pinaud M; Villers D; Nicolas F
Nouv Presse Med; 1982 Oct; 11(38):2847-8. PubMed ID: 7177819
[No Abstract] [Full Text] [Related]
33. [Proteinuria after infusion of gelatin. Comparison of Plasmion and Haemaccel].
Lazard T; Deswartes-Pipien I; Tenenhaus D; Voitot H; Drupt F; Desveaux N; Cousin MT
Therapie; 1989; 44(4):269-74. PubMed ID: 2595645
[TBL] [Abstract][Full Text] [Related]
34. A case of hypersensitivity to gelafundin.
Ong EL
Singapore Med J; 2001 Apr; 42(4):176-7. PubMed ID: 11465319
[TBL] [Abstract][Full Text] [Related]
35. Infusion of plasma expanders may lead to unexpected results in urinary protein assays.
de Keijzer MH; Klasen IS; Branten AJ; Hordijk W; Wetzels JF
Scand J Clin Lab Invest; 1999 Apr; 59(2):133-7. PubMed ID: 10353327
[TBL] [Abstract][Full Text] [Related]
36. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
[No Abstract] [Full Text] [Related]
37. [A major intolerance reaction related to the injection of modified fluid gelatin. Apropos of 1 case].
Benbunan M; Pavie-Fischer J; Reviron J
Anesth Analg (Paris); 1976; 3(4):709-12. PubMed ID: 1015657
[No Abstract] [Full Text] [Related]
38. [Anaphylactic reaction resulting from the administration of gelatin-base plasma expanders].
Meisel G; Zöckler H
Bibl Haematol; 1971; 37():348-53. PubMed ID: 5138921
[No Abstract] [Full Text] [Related]
39. [Anaphylactoid reaction to Physiogel SRK 4%--a contribution to the controversy about plasma substitutes].
Cron TA; Gerber H
Schweiz Med Wochenschr; 1991 Nov; 121(48):1773-6. PubMed ID: 1688371
[TBL] [Abstract][Full Text] [Related]
40. [Allergic immunobiology and anesthesiology].
Sabbah A; Hassoun S; Drouet M; Lauret MG; Loiry M; el Founini M; Guittot M; Sainte-Laudy J
Allerg Immunol (Paris); 1998 Jun; 30(6):173-6. PubMed ID: 9684038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
